chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chills; Body ache; Extreme Lethargy; I am running fever; have been very congested sometimes I started coughing a lot; This is a spontaneous report from a contactable consumer reported for herself.   A 41-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE),( Confirmed as Pfizer Covid vaccine) via an unspecified route of administration, administered in arm left on 19Apr2021 at the age of 41-years-old (Batch/Lot Number: EP7533) as single dose for covid-19 immunisation.  There were no medical history and concomitant medications. The patient stated she had the Covid vaccine on Monday on 19Apr2021 and she have been very congested sometimes. Today, she started coughing a lot. She had also sometimes had other side effects like chills, body ache, and extreme lethargy and today she was running fever. The patient asked if she should go to the doctor and if this was a normal side effect. When probed for treatment, patient stated she took some Tylenol. The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
Site of injection still hurts, after 1 1/2 months but it has been improving.
Patient got the Spikevax Covid-19, MRNA Vaccine on 9/29/23 at pharmacy. On 10/04/23 pt called and spoke to pharmacist on duty. She expressed her concerns of rash, inflammation and tender at site of injection. Pt also called her PCP that morning. The PCP prescribed Steroids for her discomfort. I reached out to the patient this morning  10/05/23 to follow up. she sated she felt a lot better after starting the steroid regimen.  i told let us know if there is anything else we can help with.
Afternoon of 10/3/04, developed hives. I began taking Benadryl every 6-7 hrs which controlled itching somewhat. Afternoon of 10/5/04, eyes began feeling scratchy/puffy and were slightly swollen. Morning of 10/6/04, eyes, earlobes, face, neck were severly swollen. Doctor administered two shots, prescribed Prednisone (20mg 3X's daily, and to take Benadryl (25-50mg every 6 hrs for a least 4-6 more doses).
Weight decreased from 132 to 130 pounds; Loose bowels with red tint; Loose bowels with red tint; Gas; Itchy eyes; Right eye was swollen; Look like she had the flu; A spontaneous report was received from a consumer concerning a 83 year old female patient, who  experienced itchy eyes (eye pruritus), right eye was swollen (eye swelling), looked like she had the flu (flu like symptoms), loose bowels with red tint (diarrhea and faeces discoloured), gas (flatulence), and weight decreased from 132 to 130 pounds (weight decreased).  The patient's medical history included bowel resection.  Products known to have been used by the patient, within two weeks prior to the events, included plantago ovata.  On 04 Jan 2021, the patient received their first of two planned doses of mRNA-1273 in her left arm for prophylaxis of COVID-19 infection.  On 04 Jan 2021, after receiving the vaccine, the patient experienced uncontrollable itching in both eyes and her right eye getting swollen.  It looked like she had the flu.    On 05 Jan 2021, the patient began having loose bowels with a red tint that lasted through the night (3-4 times).  She had a lot of gas which began last night (05 Jan 2021) that continued into the morning. The patient reported that the itching and swollen eye was improved.  On 06 Jan 2021, the patient stated that her weight decreased from 132 to 130 pounds.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome, itchy eyes (eye pruritus) and right eye was swollen (eye swelling), were considered recovering.  The outcome for the events of looked like she had the flu (flu like symptoms), loose bowels with red tint (diarrhea and faeces discoloured), gas (flatulence), and weight decreased from 132 to 130 pounds (weight decreased) was considered unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Pt presented for 2nd dose Moderna, but was given pfizer vaccine instead in left deltoid. adminitrator error
On 10/2 it was warm and red.  Continues to be warm, red + very painful.  On 10/7 2 knots formed.
Fever CHILLS, LEFT ARM PAIN, WEAKNESS Narrative:  Other Relevant History:
Received injection 01/04/2021.  had chills, pain in arm, muscle pain since injection.    On 01/11/2021 had COVID sx, on 01/12/2021 tested positive for COVID. My employee health clinic at work place advised I notify VEARS.
6/13 8:00am woke up with headache & full body ache. Lasted all day.  11:00pm mid back & chest pain (spasms) 8/10 on pain scale. Took one ibuprofen and went to sleep at 12:00am.  2:30am woke up covered in sweat, nausea, chest pain 10/10 on pain scale. Went to ER.  3:15am EKG - bradycardia HR 42 bpm. Zofran & morphine given for pain/nausea. Labs drawn.  CT Scan to r/o aortic dissection. Came back normal.  Chest X-RAY completed.  Mylanta given PO.  Pain improved to a 4/10 during bradycardia episodes. HR still fluctuated between mid 60?s and low 40?s with correlating chest pain during bradycardia.  8:00am admitted to telemetry unit. EP consulted. Echo completed. Normal results. Bradycardia continued. Pain 0-2/10 on pain scale.  2:00pm discharged with Bradycardia continuing. Follow up with MD & EP.
Debilitating pain, pain worsened; Stomach pain; Headache; Slept all day; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SOMNOLENCE (Slept all day), PAIN (Debilitating pain, pain worsened), ABDOMINAL PAIN UPPER (Stomach pain) and HEADACHE (Headache) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No adverse event history). Concomitant products included WARFARIN, GLIPIZIDE and METFORMIN for an unknown indication.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced SOMNOLENCE (Slept all day). On 03-Mar-2021, the patient experienced PAIN (Debilitating pain, pain worsened), ABDOMINAL PAIN UPPER (Stomach pain) and HEADACHE (Headache). On 01-Mar-2021, SOMNOLENCE (Slept all day) had resolved. On 18-Mar-2021, PAIN (Debilitating pain, pain worsened), ABDOMINAL PAIN UPPER (Stomach pain) and HEADACHE (Headache) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Mar-2021, Blood test: inconclusive (Inconclusive) Five blood tests. On 06-Mar-2021, Computerised tomogram: inconclusive (Inconclusive) Inconclusive. On 06-Mar-2021, Magnetic resonance imaging: inconclusive (Inconclusive) For contrast Imaging.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.  On 06 Mar 2021, pain worsened and the patient went to emergency room. The health care provider in the emergency room checked for the evidence of stroke. They mentioned these symptoms attributing to the side effect of the vaccine.
After 5-10 minutes started having acute episode of coughing, angioedema of face. Increased HR >180, O2 sat fluctuated from 80-90's -> gave 1 dose of BENADRYL -> after HR decreased 140's, did albuterol HPN and PO prednisolone. Still wheezing.
Client received .5cc Varicella vaccine at Health Department on 10-23-07. On 10-25-07 client presents to clinc with approximately 3" area swelling with redness to left arm injection site, tender to touch, ENC. Mother to continue cold compress and given Benadryl p.o. enc. Mother to report to M.D. ASAP if symptoms continue or worsen.
Headache, Myalgia, Fever & Rash Narrative;  Fever 100. Had nickel-sized red rash at injection site next day. Taking Ibuprofen for fever. Felt much better the next day.
Rash: red papules about 10. Multiple hard erythematous papules, several on the LE with vesicles.
The patient is 13 years old and should have received an adult dose of Pfizer drawn from the adult dosing vial of Pfizer. The patient received the children's dose drawn from a children's vial of Pfizer.
Pt recv vax on 3/16/99; on 3/18/99 swelling/  erythema/ throbbing around elbow
This is a spontaneous report from a non-contactable consumer. A patient of unspecified age, ethnicity, and gender received PREVNAR, via an unspecified route of administration on an unspecified date at a single dose. The patient's medical history and concomitant medications were not reported. On an unknown date, the patient experienced red around the spot of the shot that was getting bigger. The clinical outcome of the event, vaccination site erythema, was unknown. No follow up attempts possible. No further information expected.
After HPV administered client apparently had a seizure. Lasted approx 5 min. B/P 100/60, color appeared pale. Had sluggish capillary refill. After 5 minutes, client coherent and said she felt nauseous, and she needed to use restroom. Also to return next week accompanied per mother/sister. On their way she found physician.
Headache, Myalgia, Fever, Diarrhea, chills, night sweats Narrative: would have missed work if had to report to facility-telework
No adverse event; First dose was administered on 19-Jan-2021 and second dose on 26-Mar-2021; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose was administered on 19-Jan-2021 and second dose on 26-Mar-2021) and NO ADVERSE EVENT (No adverse event) in an 89-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 4782590) for COVID-19 prophylaxis.     The patient's past medical history included Platelets increased in April 2020. Concurrent medical conditions included Tonsillectomy, Leukemia (Bone Marrow Biopsy) since January 2021, Leukemia (Bone Marrow Biopsy) since 01-Jan-2021, Allergic reaction to analgesics, Drug allergy, Ill-defined disorder, Physical therapy, Motor dysfunction, Walking difficulty and Strength loss of. Concomitant products included VENETOCLAX (VENCLEXTA) for Acute myeloblastic leukaemia, HYDROCODONE BITARTRATE and ACETAMINOPHEN for an unknown indication.    On 26-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose was administered on 19-Jan-2021 and second dose on 26-Mar-2021). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose was administered on 19-Jan-2021 and second dose on 26-Mar-2021) and NO ADVERSE EVENT (No adverse event) outcome was unknown.            Reportedly, patient was not making progress with his hemoglobin.  Treatment details were not reported by the reporter.   This case was linked to MOD-2022-662671 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-Oct-2022: Follow-up document contains updated patient demographics.
1640 female with epistaxis evening of vaccination adm. following day pt dev. L. arm shaking, tremor. L arm felt heavy, achy and was shaking P142 bmp. Resolved, until following day felt L. arm heaviness and pain-resolved. Pt seen recovered at exam.
Information has been received from a nurse concerning a 25 year old female who on 20-MAR-2009 was vaccinated with GARDASIL (lot number 659184/0843X) 0.5 ml IM (site not reported). Concomitant therapy included XANAX. On approximately 20-MAR-2009, "a week" ago the patient developed a welt at the injection site. It was unspecified if the patient sought medical attention. The outcome was unknown. Additional information has been requested.
temperature excursion which occurred from 19Dec2021 to 22Dec2021, the temperature dropped to 33.98 degrees Fahrenheit for (27) hours, due to an unknown cause, with no adverse event; Initial information received on 11-Jan-2022 regarding an unsolicited valid non-serious case was received from the health professional.  This case involves an unknown age and unknown gender patient who had temperature excursion which occurred from 19dec2021 to 22dec2021, the temperature dropped to 33.98 degrees fahrenheit for (27) hours, due to an unknown cause, with no adverse event while receiving vaccine influenza quadrival a-b high dose hv vaccine [Fluzone High-Dose Quadrivalent].  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE at a dose 0.7 ml (strength and form: unknown; lot number: UJ715AC and expiry date: 30-Jun-2022) via unknown route in unknown administration site for flu vaccine.  On 19-DEC-2021, the patient developed a non-serious event 'temperature excursion which occurred from 19dec2021 to 22dec2021, the temperature dropped to 33.98 degrees fahrenheit for (27) hours, due to an unknown cause, with no adverse event' (product temperature excursion issue) (unknown latency) following the administration of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE.  It was reported 'RN reporting a temperature excursion which occurred from 19Dec2021 to 22Dec2021, the temperature dropped to 33.98 degrees Fahrenheit for (27) hours, due to an unknown cause, on the product FLUZONE HIGH-DOSE QUADRIVALENT, RN states that this occurred at one of their satellite offices and suspects the temperature dropped outside and the heat was never adjusted, this is reported as a potential AE because of temperature excursion. To be evaluated by PV. No further information provided by the reporter. First time product used : No Still using product : Yes'  Action taken with QUADRIVALENT INFLUENZA VACCINE (FLUZONE HIGH-DOSE QUADRIVALENT) was not applicable.  At time of reporting, the outcome was Unknown for the event 'temperature excursion which occurred from 19dec2021 to 22dec2021, the temperature dropped to 33.98 degrees fahrenheit for (27) hours, due to an unknown cause, with no adverse event'.
Itching (Internal) all over within 30 min following vaccination.  Took Benadryl
About 2-3 minutes after receiving the shot in my left arm, I began to get extremely disoriented. I lost my vision in in both eyes and completely lost my sense of direction. So much so that I walked into several walls in the isles. After regaining vision about a minute after, I began to search for my father who had came with me. As I walked, I felt very heavy like a huge weight was pulling me down. I began to feel flush like a change in temperature but not almost like a tingling but over my whole body. During that time I began to sweat and my walking was heavy like I was carrying extra weight. A few times I had to stop walking and catch my breath but I was not overwhelmed by movement but more so something had come over me as if my body didn?t like what was going on. Once I located my father, I let him know I wasn?t feeling well after receiving the shot. I became thirsty and needed some hydration so I purchased a soda while feeling very fatigued and sweating profusely. I also purchased a candy bar as I had not eaten and hoped it would help. After my purchase I went back to the pharmacy and explained what I had went through. I ate the candy bar and drank the soda and after about 5 minutes I realized what I needed from the store. I advised the doctor that it seemed to go away and that I was no longer feeling the same symptoms. No  explanation was given but was told I could go. Snce then I have had this weird feeling in my head like I am about to get a headach but it never comes just there like it wants to start or something but I just wanted to share my experience because I have not heard anything about what I went theough.
Pt had been on ATB for ear infect but had no fever; Evening of vax was drowsy & slept a lot; fever devel 11APR92 up to 102; took 6 doses of APAP to bring fever down; adm to hosp 12APR until 15APR92 for dehydration;
Information has been received from a nurse practitioner concerning a 17 year old female patient with no family history of seizure disorder and no past medical history of seizure disorder who on 09-SEP-2010 was vaccinated with the first dose of GARDASIL (Lot # 666118/1539Y). The patient did not receive any concomitant vaccinations at the time of GARDASIL was administered. The nurse reported that the patient left the office with her mother after the GARDASIL vaccination had been administered. Within 15 minutes after the GARDASIL vaccination had been administered the patient had a "seizure-like episode" (also reported as a grand mal seizure) while being driven home by her mother. The patient's mother stated that her daughter's eyes rolled to the back of her head and patient began to flail her extremities. The patient was taken back to the physician's office and was seen in the Urgent Care Center which is contained in the physician's facility. The patient did not remember having the "seizure-like episode". The patient was not hospitalized. On 10-SEP-2010, the patient's mother stated that she kept her daughter home from school on Friday and planned to send her to school on Monday, 13-SEP-2010. The patient's mother stated that her daughter had recovered. The patient had been referred to a Pediatric Neurologist. The GARDASIL series had been discontinued. Upon internal review, seizure-like episode was considered to be an other important medical event. Additional information has been requested.
Pt here for bivalent booster pfizer dose but incorrectly given the monovalent,primary series pfizer vaccine instead.  No side effects reported following administration.  Pt's caregiver spoke with vax site provider and recommended bivalent in 2 months.
Vomiting, can't eat or drink without vomiting 1 day after shot. When tried to eat, vomited repeatedly.  Other symptoms include fever,  achy limbs, and a severe headache and sleepiness.
Cold chills, body aches, headache about 8 hours after the vaccinne was administered.  Symptoms subsided 20 hours later. At around 6:30 the following day the chills came back for about 8 hours.
11/09/2020 - Tested positive for COVID-19  02/08/2021 & 03/01/2021 - Received Pfizer COVID-19 vaccines 06/29/2021 - Tested positive for COVID-19 at Hospital 06/29/2021 - Admitted to Medical Center / Hospital  06/30/2021 - Tested negative for COVID-19 at  Medical Center / Hospital 06/30/2021 - Discharged from Medical Center / Hospital
Dizziness; Exhaustion; Nausea; Arm pain; Lack of balance; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), FATIGUE (Exhaustion), NAUSEA (Nausea), PAIN IN EXTREMITY (Arm pain) and BALANCE DISORDER (Lack of balance) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness), FATIGUE (Exhaustion), NAUSEA (Nausea), PAIN IN EXTREMITY (Arm pain) and BALANCE DISORDER (Lack of balance). At the time of the report, DIZZINESS (Dizziness), FATIGUE (Exhaustion), NAUSEA (Nausea), PAIN IN EXTREMITY (Arm pain) and BALANCE DISORDER (Lack of balance) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Patient is a new arrival.  Patient requested a first dose COVID vaccine upon arrival to facility. All documentation completed with patient. Patient denied ever receiving any COVID vaccine prior to this date. Medical staff administered 1st dose Moderna vaccine to patient on 4/22/2021. Upon entering vaccine into. Patient record shows she received the Pfizer vaccine on 2/15/2021. Patient reports she "forgot she received the vaccine." Patient denies any adverse reaction to Moderna Vaccine on 4/22/2021.
Headaches all day 2/25 and 2/27, tingling in left arm and around mouth on 2/27 for 3 hours. No treatment.  Headaches still occurring.
Teen was give Dtap instead of Tdap, was informed by State vaccine nurse consultant to fill out Vaers
tested positive for COVID-19 on 04Aug2021; tested positive for COVID-19 on 04Aug2021/ Cold symptoms; This is a spontaneous report from a contactable other health professional. A 34-years-old unknown pregnant female patient received first dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Solution for injection, Lot Number ER2613, Expiration date: unknown) intramuscularly, administered in arm left on 31Mar2021 as dose 1, single and received second dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Solution for injection, Lot Number ER2613, Expiration date: unknown) intramuscularly, administered in arm right on 20Apr2021 as dose 2, single for COVID-19 immunization at workplace clinic (34 years when vaccinated). The patient medical history and concomitant medications were not reported. It was unknown that the patient diagnosed with COVID-19 prior to vaccination. Known allergies was unknown. It was unknown that the patient received any other vaccines within 4 weeks prior to the COVID vaccine and any other medications the patient received within 2 weeks of vaccination. Other medical history was unknown. On 04Aug2021, the patient started experiencing cold symptoms and on the same day the patient was also diagnosed with covid-19. On 04Aug2021, the patient had tested herself for Sars-Cov-2 infection via Nasal Swab and results were positive. The patient was not treated for the events. The outcome of the events was reported as not recovered.; Sender's Comments: Based on known drug safety profile, there is reasonable possibility of causal association between the events vaccination failure and covid-19 and the suspect drug BNT162B2.
This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient. Other Case identifier(s): US-ABBVIE-22K-163-4506816-00  An 86-year-old female patient received BNT162b2 (BNT162B2), on 10Feb2021 as dose 1, single (Batch/Lot number: unknown), on 04Mar2021 as dose 2, single (Batch/Lot number: unknown), on 15Aug2021 as dose 3 (booster), single (Batch/Lot number: unknown) and on 01Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 86 years, all intramuscular for covid-19 immunisation. The patient's relevant medical history included: "Non-tobacco user" (unspecified if ongoing); "No alcohol use" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 15Aug2022, outcome "recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (15Aug2022) Positive, notes: have Covid.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Breakthrough COVID case: I found out about exposure on Monday, the 30th. That night, I began to feel a scratchy throat. The scratchy throat continued until at least Thursday. I also began to have nasal congestion and a brief slight headache. I tested 5 times between Monday night and Thursday. Every result was negative until Thursday morning when I got a positive result. I had a doctor's appointment where I was prescribed PAXLOVID. I received my prescription and started treatment on the evening of Friday, the 3rd. For the next day and a half or 2 days, I continued to have congestion but less of it. Symptoms disappeared for the most part by Monday, the 6th. I began to test negative on the evening of the 6th. I completed the PAXLOVID treatment on June 8th and I've continued to test negative since June 7th.
I am a Covid survivor (January, 2021) and the reaction to the vaccine was exactly the same as my Covid symptoms.  Extreme lethargy, headache,  sleepiness.  I could hardly make it across the room and was not able to go into work.  This lasted about 24 hours.  I will not be taking the second shot.